Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MS2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,809
Award facts
- Contract value 100% obligated
- $10,809.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,809.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Dupixent 200 mg/1.14 ml pen (1.14 ml). The contract, with an ultimate completion date of January 26, 2026, was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent is a biologic treatment used for immunological and inflammatory conditions including atopic dermatitis, asthma, and eosinophilic diseases. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen Drug Corp fulfills essential pharmaceutical needs across the Defense Health Agency and military treatment facilities. The competitively awarded contract structure and AmerisourceBergen's extensive federal contracting portfolio demonstrate the vendor's established capability to meet rigorous government procurement requirements for specialized pharmaceutical products in support of military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9MS2?
SPE2DR26F9MS2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F9MS2 worth?
The government has obligated $10,809 on SPE2DR26F9MS2.
Is contract SPE2DR26F9MS2 an order under another contract?
Yes. SPE2DR26F9MS2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MS2 competed?
The extent of competition for SPE2DR26F9MS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award